Retinal Physician

Retinal Physician Therapeutic and Surgical Treatment of the Posterior Segment

Improved research facilities and collaborative networks are establishing Argentina as a reliable partner for global opht...
12/03/2025

Improved research facilities and collaborative networks are establishing Argentina as a reliable partner for global ophthalmology studies, notes Patricio G. Schlottmann, MD. Read more: https://ow.ly/kBBF50XpXkP

Belite Bio reports positive topline results from its phase 3 DRAGON trial evaluating tinlarebant in adolescents with Sta...
12/02/2025

Belite Bio reports positive topline results from its phase 3 DRAGON trial evaluating tinlarebant in adolescents with Stargardt disease. Read more: https://ow.ly/ZQ6g50XAAx4

Kevin J. Corcoran, COE, FNAO, provides an overview of coding, billing, and reimbursement for photobiomodulation. Read mo...
12/01/2025

Kevin J. Corcoran, COE, FNAO, provides an overview of coding, billing, and reimbursement for photobiomodulation. Read more: https://ow.ly/OqRR50XpXaK

CMS will increase reimbursement for vitrectomy and other retina surgeries in the in 2026. Read more: https://ow.ly/EQH...
11/26/2025

CMS will increase reimbursement for vitrectomy and other retina surgeries in the in 2026. Read more: https://ow.ly/EQH550XxQIL

This Thanksgiving season, Editor in Chief Diana V. Do, MD, is grateful for the retina community’s collaboration and shar...
11/26/2025

This Thanksgiving season, Editor in Chief Diana V. Do, MD, is grateful for the retina community’s collaboration and sharing of knowledge. Read more: https://ow.ly/MusQ50XpL2i

Video: In November’s Retina Minute, Michael Singer, MD, speaks with David Eichenbaum, MD, about AI and nAMD conversion b...
11/25/2025

Video: In November’s Retina Minute, Michael Singer, MD, speaks with David Eichenbaum, MD, about AI and nAMD conversion biomarkers. Watch here: https://ow.ly/ZWbU50XpX73

The FDA has approved Regeneron’s Eylea HD for , and changed the label to permit 4-week dosing for all indications. Read...
11/24/2025

The FDA has approved Regeneron’s Eylea HD for , and changed the label to permit 4-week dosing for all indications. Read more: https://ow.ly/TA2q50Xx2YG

Priya Vakharia, MD, explains how vorolanib, axitinib, and migaldendranib may offer sustained and targeted therapy for nA...
11/24/2025

Priya Vakharia, MD, explains how vorolanib, axitinib, and migaldendranib may offer sustained and targeted therapy for nAMD and DME. Read more: https://ow.ly/ExZO50XpWs3

In this month’s Coding Q&A, Elizabeth Cifers offers tips to minimize denials, reduce audit risk, and maintain a smooth o...
11/21/2025

In this month’s Coding Q&A, Elizabeth Cifers offers tips to minimize denials, reduce audit risk, and maintain a smooth operation. Read more: https://ow.ly/YGRA50XpWyP

Address

321 Norristown Road
Ambler, PA
19382

Website

Alerts

Be the first to know and let us send you an email when Retinal Physician posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Retinal Physician:

Shortcuts

Share

Category